Studying pre-treatment and ketamine-induced changes in white matter microstructure in the context of ketamine’s antidepressant effects

Abstract

Ketamine is increasingly being used as a therapeutic for treatment-resistant depression (TRD), yet the effects of ketamine on the human brain remain largely unknown. This pilot study employed diffusion magnetic resonance imaging (dMRI) to examine relationships between ketamine treatment and white matter (WM) microstructure, with the aim of increasing the current understanding of ketamine’s neural mechanisms of action in humans. Longitudinal dMRI data were acquired from 13 individuals with TRD two hours prior to (pre-infusion), and four hours following (post-infusion), an intravenous ketamine infusion. Free-water imaging was employed to quantify cerebrospinal fluid-corrected mean fractional anisotropy (FA) in 15 WM bundles pre- and post-infusion. Analyses revealed that higher pre-infusion FA in the left cingulum bundle and the left superior longitudinal fasciculus was associated with greater depression symptom improvement 24 h post-ketamine. Moreover, four hours after intravenous administration of ketamine, FA rapidly increased in numerous WM bundles in the brain; this increase was significantly associated with 24 h symptom improvement in select bundles. Overall, the results of this preliminary study suggest that WM properties, as measured by dMRI, may have a potential impact on clinical improvement following ketamine. Ketamine administration additionally appears to be associated with rapid WM diffusivity changes, suggestive of rapid changes in WM microstructure. This study thus points to pre-treatment WM structure as a potential factor associated with ketamine’s clinical efficacy, and to post-treatment microstructural changes as a candidate neuroimaging marker of ketamine’s cellular mechanisms.

Brain Ventricle and Choroid Plexus Morphology as Predictor of Treatment Response: Findings from the EMBARC Study

“…Regarding the relationship of DTI parameters, no relationship with clinical change was observed. This is in contrast to studies, which reported DTI parameters as predictive for response, for example to ketamine 64,65 . Nevertheless, we observed that the volume of CC segments correlated inversely with axial diffusivity (AD), i.e.…”

Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine

“…Ketamine use has been shown to result in neuroplasticity and neurogenesis, demonstrating lasting structural and functional neurological changes. Ketamine use in treatment-resistant depression resulted in rapid changes in white matter diffusivity and microstructure [ 57 ]. In this population, a single dose of ketamine has been shown to produce rapid relief of symptoms that lasts up to 2 weeks [ 58 ].…”

Anterior default mode network and posterior insular connectivity is predictive of depressive symptom reduction following serial ketamine infusion

“…Here, we observed more reduced HDRS-6 and CMA symptoms among patients with lower DK in the right SLF that may suggest that depression-related microstructural abnormalities of the SLF are indicative of subsequent responsivity to SKI. Related to these findings, a pilot study on 13 patients with treatment-resistant depression who received a single infusion of ketamine reported that higher FA of the left SLF was associated with better symptom improvement 24 h post-infusion (Sydnor et al, 2020 ).…”